Cardiovascular risk factors in depression. The role of anxiety and anger

Psychosomatics
M FavaJ F Rosenbaum

Abstract

The authors hypothesized that patients with anxious or hostile depression may have a greater risk of mortality from coronary artery disease (CAD) than other depressed patients and therefore proceeded to assess the possible relationship between CAD risk factors and anger and anxiety in a sample of 138 depressed outpatients. The authors observed that increased anxiety scores were associated with higher cholesterol levels and with prolonged QTc intervals. Similarly, the patients with anger attacks tended to have higher cholesterol levels compared with the patients without these attacks. The study's findings partially support the authors' hypothesis that hostile or anxious depressed patients are at greater risk for CAD than other depressed patients.

References

Jan 1, 1979·The American Journal of Medicine·A J Moss, P J Schwartz
Mar 1, 1992·The American Journal of Psychiatry·W K BajwaH M van Praag
Mar 29, 1990·The New England Journal of Medicine·J E MansonC H Hennekens
Jul 1, 1989·Psychosomatic Medicine·M H HuangS Wolf
Mar 1, 1987·Journal of Affective Disorders·W R Yates, R Wallace
Nov 28, 1986·JAMA : the Journal of the American Medical Association·S M Grundy
Aug 1, 1987·Psychiatry Research·E C VillacresR C Veith
Dec 5, 1986·JAMA : the Journal of the American Medical Association·A J Moss
May 1, 1974·Pharmakopsychiatrie, Neuro-Psychopharmakologie·J E Overall
Nov 23, 1984·JAMA : the Journal of the American Medical Association·J P VandenbrouckeR M van der Heide
Mar 1, 1983·Psychosomatic Medicine·J C BarefootR B Williams
May 1, 1983·Psychosomatic Medicine·R B ShekelleO Paul
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Dec 20, 2000·Journal of Psychosomatic Research·J Denollet
Jul 6, 2000·Journal of Psychosomatic Research·F Lespérance, N Frasure-Smith
Jun 12, 2003·Psychiatry Research·George I PapakostasMaurizio Fava
Mar 12, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·George I PapakostasMaurizio Fava
Mar 20, 2001·Bipolar Disorders·S N GhaemiF K Goodwin
Oct 24, 2002·Acta Psychiatrica Scandinavica·S LuutonenR K R Salokangas
Feb 15, 2007·The Journal of Nervous and Mental Disease·Dan V IosifescuMaurizio Fava
Oct 6, 2009·Biochimica Et Biophysica Acta·Heidi ScrableSilvia Medrano
Mar 11, 2004·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Jorge CervillaSimon Lovestone
May 8, 2007·Physiology & Behavior·Gui-Hai ChenJiang-Ning Zhou
Dec 21, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Paolo Fusar-PoliPierluigi Politi
Nov 24, 2011·Depression Research and Treatment·Floor E A VerhoevenA J Willem Van der Does
Jul 5, 2006·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Paolo Fusar-PoliPierluigi Politi
Nov 19, 2003·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Fabienne DobbelsJohan Vanhaecke
Jul 25, 2007·International Journal of Psychiatry in Medicine·Renerio FraguasMaurizio Fava
Jul 10, 2002·Periodontology 2000·Esmonde F CorbetEdward C M Lo
Feb 28, 2001·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·L SevincokF Dereboy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.